Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DK5JP3
|
|||
| Drug Name |
GZ17-6.02
|
|||
| Indication | Lymphoma [ICD-11: 2A80-2A86; ICD-10: C81-C86; ICD-9: 202] | Phase 1 | [1] | |
| Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C00-D48; ICD-9: 140-199] | Phase 1 | [1] | ||
| Company |
Genzada Pharmaceuticals
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03775525) Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or Lymphoma (GEN602). U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.